CE-IVD Oncology Applications by SOPHiA GENETICS™
Supporting fast and reliable precision diagnostics with CE-IVD applications powered by SOPHiA DDM™
Discover our CE-IVD Oncology Solutions
We are here to simplify your transition to the new regulatory environment. You can leverage our CE-in vitro diagnostic (IVD) labeled platform and CE-IVD Oncology Applications while staying compliant with IVDD during this transition period. See in our Frequently Asked Questions section for more answers.
Get ready for a streamlined workflow –
From sample to data to insight
Our CE-IVD Oncology Applications provide you with robust, meaningful clinical results and help you to discover the full power of your data for your patients. Leverage the potential of an end-to-end CE-IVD solution in oncology genetic testing and reporting.
Accurate and reliable testing
Confident detection of actionable variants
Reduced time to patient benefit
EU IVDD compliant solutions and software
Contact us to know more
Discover our CE-IVD Oncology Applications
SOPHiA DDM™ Dx Homologous Recombination Deficiency (HRD) Solution
Support accurate detection of HRD status in ovarian cancer patients by leveraging low-pass WGS to measure genomic scarring.
SOPHiA DDM™ Dx RNAtarget Oncology Solution (ROS)
Expect more from your RNA analyses with reliable partner-agnostic detection of fusions in small lung cancer biopsy samples.
SOPHiA DDM™ Dx Solid Tumor Solution (STS)
Benefit from advanced molecular profiling of solid tumors, including lung, colorectal, skin and brain, with confident SNV and Indel detection in relevant genes.
SOPHiA DDM™ Dx Myeloid Solution (MYS)
Expand the scope of myeloid neoplasms management with advanced analytical performance for the detection of pertinent SNVs, Indels and FLT3-ITDs.
SOPHiA DDM™ Dx Hereditary Cancer Solution (HCS)
Confidently assess crucial variants associated with hereditary cancers with tailored analytics that accurately detect key SNVs and Indels.
Indels, insertions/deletions. ITDs, internal tandem duplications; SNVs, single nucleotide variants; WGS, whole genome sequencing